Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TIA1 anticorps (AA 279-380)

Cet anticorps Souris Monoclonal détecte spécifiquement TIA1 dans WB, IF et FACS. Il présente une réactivité envers Humain.
N° du produit ABIN7127001

Aperçu rapide pour TIA1 anticorps (AA 279-380) (ABIN7127001)

Antigène

Voir toutes TIA1 Anticorps
TIA1 (TIA1 Cytotoxic Granule-Associated RNA Binding Protein (TIA1))

Reactivité

  • 75
  • 30
  • 29
  • 5
  • 5
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 58
  • 16
  • 1
Souris

Clonalité

  • 49
  • 26
Monoclonal

Conjugué

  • 36
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp TIA1 est non-conjugé

Application

  • 43
  • 22
  • 18
  • 17
  • 14
  • 13
  • 10
  • 9
  • 6
  • 5
  • 5
  • 3
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)
  • Épitope

    • 15
    • 9
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 279-380

    Specificité

    TIA-1 (T-cell intracytoplasmic antigen) is a cytoplasmic granule-associated protein, expressed in lymphocytes processing cytolytic potential. TIA-1 is a member of an RNA-binding protein family and possesses nucleolytic activity against cytotoxic lymphocyte (CTL) target cells. It has been suggested that this protein may be involved in the induction of apoptosis as it preferentially recognizes poly(A) homopolymers and induces DNA fragmentation in CTL targets. The major granule-associated species is a 15 kDa protein thought to be derived from the carboxyl terminus of the 40 kDa product by proteolytic processing. TIA1 antibody labels cytotoxic T cells and natural killer cells (NK cells). It is also expressed in T-cell lymphoma, large granular lymphocyte (LGL) leukemia and hairy cell leukemia. TIA1 expression in T-cell malignancies may help in differentiating LGL leukemia (high expression) from T-cell lymphocytosis and other T-cell diseases (low expression). TIA1 may also be used to label tumor-infiltrating lymphocytes in the study of immune response to malignancies.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant human TIA1 fragment of 102 amino acid residues (aa279-380)

    Isotype

    IgG2b
  • Indications d'application

    Known_Application: Flow Cytometry (0.5-1 μg/million cells in 0.1ml), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL for 60 minutes at RT),Optimal dilution for a specific application should be determined.

    Positive_Control: HepG2, PC3 or HeLa cells. Human tonsil.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    TIA1 (TIA1 Cytotoxic Granule-Associated RNA Binding Protein (TIA1))

    Autre désignation

    TIA1

    Sujet

    Cytotoxic granule associated RNA binding protein 1, mTIA-1, Nucleolysin TIA1 isoform p40, p40-TIA-1, RNA binding protein TIA1, T-cell-restricted intracellular antigen-1 (TIA1), TIA-1, TIA1, TIA1 cytotoxic granule associated RNA binding protein, TIAL1, TIAR, WDM,TIA1 (T-Cell-Restricted Intracellular Antigen-1)
    Cellular localisation: Cytoplasmic

    Poids moléculaire

    40kDa

    ID gène

    7072, 413123

    UniProt

    P31483
Vous êtes ici:
Chat with us!